IndraLab

Statements


Serotonin increases the amount of KCNK2. 1 / 1
| 1

reach
"Fluoxetine, a serotonin reuptake inhibitor antidepressant that has been previously found to inhibit TREK-1 channels, robustly, could attenuate the upregulation of TREK-1 expression and the inhibition of NSC proliferation induced by dexamethasone."